Patient assessments of ease of use of Genuair® versus Aerolizer® and HandiHaler®

R. Fuhr, H. Magnussen, D. Singh, G. de Miquel, C. Caracta, E. Garcia Gil (Berlin, Grosshansdorf, Germany; Manchester, United Kingdom; Barcelona, Spain; , United States Of America)

Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Session: Drug delivery and pharmacokinetics II
Session type: Thematic Poster Session
Number: 3979
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Fuhr, H. Magnussen, D. Singh, G. de Miquel, C. Caracta, E. Garcia Gil (Berlin, Grosshansdorf, Germany; Manchester, United Kingdom; Barcelona, Spain; , United States Of America). Patient assessments of ease of use of Genuair® versus Aerolizer® and HandiHaler®. Eur Respir J 2011; 38: Suppl. 55, 3979

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Usability evaluation of NEXThaler® versus Diskus® and Turbuhaler®
Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma
Year: 2012

Smoking assessment & treatment in hospital: Are we providing ‘right care‘ and/or missing cannabis-smoking?
Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment
Year: 2011


Patients‘ and family members‘ worries and concerns regarding ‘swine flu‘: A mixed methods study
Source: Annual Congress 2010 - The nursing challenges and strategies when caring for patients with chronic lung disease
Year: 2010

Documentation & accuracy of smoking status – An educational need?
Source: Annual Congress 2011 - Smoking cessation science and smoking-related disorders
Year: 2011

Preference, satisfaction and critical errors with Genuair® and HandiHaler® in patients with COPD
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012

The results of drug resistance survey of MDR-strains on second line drugs obtains in national reference laboratory – " M.Nasta " Institute – Bucharest
Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2011

Clinical decision making in alpha1 antitrypsin deficiency emphysema – Methodologies to determine individual rates of FEV1 decline
Source: Annual Congress 2010 - Novel biomarkers and old parameters in approaching pulmonary diseases
Year: 2010

Optimization of inhalation treatment – Evaluation of influence of PNEUMOlogic® and Optimiser® spacers on aerosol particle distribution from pMDI-EB
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Year: 2011


Patients‘ knowledge about inhalation therapy in pulmology – One year after intervention
Source: Annual Congress 2011 - Medical education
Year: 2011

Evaluation of difficult asthma – a single centre experience
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009


Comparison between SCOT-15® and Perfadex® as lung preservation solutions
Source: Annual Congress 2011 - Immunobiology in the transplanted lung: experimental and clinical evaluations
Year: 2011


Quality of life in asthmatic children "a comparative study of patients‘ and parents‘ perceptions"
Source: Annual Congress 2011 - Coping and lifestyle in childhood asthma
Year: 2011


Late Breaking Abstract: Inhalation technique errors and education effects in the group of patients using Aerolizer® – The real life study
Source: Annual Congress 2010 - Medical education: methodology
Year: 2010

Evaluation of pulmonary diffusion: TLCO or KCO?
Source: Annual Congress 2010 - Advances in lung function I
Year: 2010

Comparative in vitro performance of a new re-usable breath-actuated nebulizer (BAN) with other high performance systems intended for domiciliary use – 2: Portable battery-compressor
Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs
Year: 2012


EGFR, HER2 and KRAS mutational status according to adenocarcinoma patterns/sub-types
Source: Annual Congress 2011 - Genetics of airway diseases and treatment
Year: 2011

Airway resistances: Raw, sRaw, sReff – Which is the best determinant of airway function?
Source: Annual Congress 2010 - Lung function from infancy to adulthood
Year: 2010


Characteristics of ‘exacerbation-prone‘ phenotype‘ based on a self-questionnaire in adult patients with asthma
Source: Annual Congress 2010 - Methods in respiratory epidemiology
Year: 2010

Impact of community pharmacists‘ interviews on patients‘ asthma control and perception of therapy and disease
Source: Annual Congress 2009 - Epidemiology of asthma
Year: 2009


Predictors of PAO2 and PaCO2 in COPD patients
Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases
Year: 2009